We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

SYSMEX-EUROPA

Sysmex Europe designs and produces laboratory and hematology diagnostic solutions, including instruments, reagents, c... read more Featured Products: More products

Download Mobile App





Sysmex Showcases Latest Laboratory Innovations and Technologies

By LabMedica International staff writers
Posted on 04 Feb 2025

Sysmex (Kobe, Japan) is participating at Medlab Middle East 2025 as a platinum sponsor where the company is showcasing its latest laboratory innovations and technologies and also hosting workshops. More...

At the 2025 edition of Medlab Middle East, Sysmex is highlighting BloodScience Workcell, its novel laboratory automation concept which smartly combines hematology and hemostasis testing in one interdisciplinary solution – to support physicians in obtaining a more holistic picture of their patients and to improve the workflow in the laboratory. BloodScience Workcell consolidates the workflow automation of EDTA and citrate blood sample tubes by combining hematology automation lines, XR-9000 or XN-9100, with the new CN track for hemostasis. Also featured is the UN-Series of urinalysis solutions which can automate a lab’s urinalysis work area according to required workflow preferences. With modular components to mix and match, labs can tailor a complete solution that is scalable to their current and future needs, providing a perfect fit and a secure investment.

Sysmex is also showcasing its comprehensive line of IVD flow cytometry products, headlined by the advanced PS-10 sample preparation system and the XF-1600 flow cytometer, in addition to an extensive portfolio of monoclonal antibodies and consumables. Sysmex is demonstrating CyFlow WA, its innovative Work Area Manager (WAM) software, which is the key to a smartly connected modern clinical flow cytometry lab. It integrates seamlessly with existing Sysmex lab equipment, acting as a powerful middleware solution bridging hematology and clinical flow cytometry data analysis.

Among its other solutions, Sysmex is showcasing HISCL-800, the latest addition to its HISCL family of automated immunoassay systems. The unique features of HISCL-800 include fast reaction time with throughput of up to 100 tests per hour, delivering highly sensitive and specific clinical results with small footprint, making it an ideal partner for small and medium-sized laboratories. With a fast reaction time for every parameter, it takes 17 mins to get the first test result. The HISCL-800’s rapid analysis enables laboratories to meet their reporting objectives, especially for STAT samples. Visitors to the Sysmex booth can also view digital displays of its cancer diagnostic solutions for breast cancer and colorectal cancer.


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Influenza Virus Test
NovaLisa Influenza Virus B IgM ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.